# Effects of Intensive Antiplatelet Therapy for Patients With Clopidogrel Resistance After Coronary Stent Implantation

> **NCT01094457** · PHASE4 · COMPLETED · sponsor: **Shenyang Northern Hospital** · enrollment: 840 (actual)

## Conditions studied

- Acute Coronary Syndromes
- Percutaneous Coronary Intervention
- Clopidogrel Low Responsiveness

## Interventions

- **DRUG:** aspirin, clopidogrel
- **DRUG:** aspirin, clopidogrel, cilostazol

## Key facts

- **NCT ID:** NCT01094457
- **Lead sponsor:** Shenyang Northern Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2012-04
- **Final completion:** 2012-06
- **Target enrollment:** 840 (ACTUAL)
- **Last updated:** 2012-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01094457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01094457, "Effects of Intensive Antiplatelet Therapy for Patients With Clopidogrel Resistance After Coronary Stent Implantation". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01094457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*